Your browser doesn't support javascript.
loading
Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.
Cole, James H; Annus, Tiina; Wilson, Liam R; Remtulla, Ridhaa; Hong, Young T; Fryer, Tim D; Acosta-Cabronero, Julio; Cardenas-Blanco, Arturo; Smith, Robert; Menon, David K; Zaman, Shahid H; Nestor, Peter J; Holland, Anthony J.
Affiliation
  • Cole JH; Computational, Cognitive & Clinical Neuroimaging Laboratory (C3NL), Division of Brain Sciences, Imperial College London, London, UK. Electronic address: james.cole@imperial.ac.uk.
  • Annus T; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Wilson LR; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Remtulla R; Medicine School, University of Birmingham, Birmingham, UK.
  • Hong YT; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
  • Fryer TD; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
  • Acosta-Cabronero J; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Cardenas-Blanco A; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Smith R; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
  • Menon DK; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Zaman SH; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Nestor PJ; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Holland AJ; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Neurobiol Aging ; 56: 41-49, 2017 08.
Article in En | MEDLINE | ID: mdl-28482213
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets of physiological aging. This includes brain atrophy, beta amyloid deposition, cognitive decline, and Alzheimer's disease-factors indicative of brain aging. Here, we employed a machine learning approach, using structural neuroimaging data to predict age (i.e., brain-predicted age) in people with DS (N = 46) and typically developing controls (N = 30). Chronological age was then subtracted from brain-predicted age to generate a brain-predicted age difference (brain-PAD) score. DS participants also underwent [11C]-PiB positron emission tomography (PET) scans to index the levels of cerebral beta amyloid deposition, and cognitive assessment. Mean brain-PAD in DS participants' was +2.49 years, significantly greater than controls (p < 0.001). The variability in brain-PAD was associated with the presence and the magnitude of PiB-binding and levels of cognitive performance. Our study indicates that DS is associated with premature structural brain aging, and that age-related alterations in brain structure are associated with individual differences in the rate of beta amyloid deposition and cognitive impairment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Aging / Amyloid beta-Peptides / Down Syndrome / Cognition Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Aging / Amyloid beta-Peptides / Down Syndrome / Cognition Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurobiol Aging Year: 2017 Document type: Article Country of publication: United States